Literature DB >> 19500105

Silent infarcts in young children with sickle cell disease.

Janet L Kwiatkowski1, Robert A Zimmerman, Avrum N Pollock, Wendy Seto, Kim Smith-Whitley, Justine Shults, Anne Blackwood-Chirchir, Kwaku Ohene-Frempong.   

Abstract

Silent infarcts have been reported most commonly in school-aged children with homozygous sickle cell disease (SCD-SS) and are associated with neurocognitive deficits. However, the prevalence of silent infarcts in younger children with SCD-SS is not well defined. In this retrospective study, brain magnetic resonance imaging and angiography (MRI/A) studies performed before 6 years of age in a cohort of children with SCD-SS were analysed and the prevalence of abnormalities was calculated. Clinical and laboratory parameters were compared between the groups with and without silent infarcts. Sixty-eight of 96 children in the cohort had brain MRI/A performed prior to age 6 years. Of the 65 who were neurologically asymptomatic, 18 (27.7%, 95% CI 17.3-40.2%) had silent infarcts (mean age 3.7 +/- 1.1 years, range 1.3-5.9 years). Factors associated with silent infarcts included cerebral vessel stensosis by magnetic resonance angiography, lower rates of vaso-occlusive pain and acute chest syndrome and lower haemoglobin levels. The prevalence of silent infarcts in young children with SCD-SS is similar to that of older children and anaemia and severe vasculopathy may be risk factors.

Entities:  

Mesh:

Year:  2009        PMID: 19500105      PMCID: PMC2793684          DOI: 10.1111/j.1365-2141.2009.07753.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  15 in total

1.  Prediction of adverse outcomes in children with sickle cell disease.

Authors:  S T Miller; L A Sleeper; C H Pegelow; L E Enos; W C Wang; S J Weiner; D L Wethers; J Smith; T R Kinney
Journal:  N Engl J Med       Date:  2000-01-13       Impact factor: 91.245

2.  Cognitive functioning and brain magnetic resonance imaging in children with sickle Cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease.

Authors:  F D Armstrong; R J Thompson; W Wang; R Zimmerman; C H Pegelow; S Miller; F Moser; J Bello; A Hurtig; K Vass
Journal:  Pediatrics       Date:  1996-06       Impact factor: 7.124

3.  Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity.

Authors:  C H Pegelow; W Wang; S Granger; L L Hsu; E Vichinsky; F G Moser; J Bello; R A Zimmerman; R J Adams; D Brambilla
Journal:  Arch Neurol       Date:  2001-12

4.  Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease.

Authors:  W C Wang; D M Gallagher; C H Pegelow; E C Wright; E P Vichinsky; M R Abboud; F G Moser; R J Adams
Journal:  J Pediatr Hematol Oncol       Date:  2000 Jul-Aug       Impact factor: 1.289

5.  Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease.

Authors:  S T Miller; E A Macklin; C H Pegelow; T R Kinney; L A Sleeper; J A Bello; L D DeWitt; D M Gallagher; L Guarini; F G Moser; K Ohene-Frempong; N Sanchez; E P Vichinsky; W C Wang; D L Wethers; D P Younkin; R A Zimmerman; M R DeBaun
Journal:  J Pediatr       Date:  2001-09       Impact factor: 4.406

6.  Cerebrovascular accidents in sickle cell disease: rates and risk factors.

Authors:  K Ohene-Frempong; S J Weiner; L A Sleeper; S T Miller; S Embury; J W Moohr; D L Wethers; C H Pegelow; F M Gill
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

7.  Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease.

Authors:  Charles H Pegelow; Eric A Macklin; Franklin G Moser; Winfred C Wang; Jacqueline A Bello; Scott T Miller; Elliott P Vichinsky; Michael R DeBaun; Ludovico Guarini; Robert A Zimmerman; Donald P Younkin; Dianne M Gallagher; Thomas R Kinney
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

8.  Abnormalities of the central nervous system in very young children with sickle cell anemia.

Authors:  W C Wang; J W Langston; R G Steen; L W Wynn; R K Mulhern; J A Wilimas; F M Kim; R E Figueroa
Journal:  J Pediatr       Date:  1998-06       Impact factor: 4.406

9.  Brain imaging findings in pediatric patients with sickle cell disease.

Authors:  R Grant Steen; Temitope Emudianughe; Gisele M Hankins; Lynn W Wynn; Winfred C Wang; Xiaoping Xiong; Kathleen J Helton
Journal:  Radiology       Date:  2003-05-29       Impact factor: 11.105

10.  MRI abnormalities of the brain in one-year-old children with sickle cell anemia.

Authors:  Winfred C Wang; Steven G Pavlakis; Kathleen J Helton; Robert C McKinstry; James F Casella; Robert J Adams; Renee C Rees
Journal:  Pediatr Blood Cancer       Date:  2008-11       Impact factor: 3.167

View more
  61 in total

1.  Discontinuing prophylactic transfusions increases the risk of silent brain infarction in children with sickle cell disease: data from STOP II.

Authors:  Miguel R Abboud; Eunsil Yim; Khaled M Musallam; Robert J Adams
Journal:  Blood       Date:  2011-06-01       Impact factor: 22.113

Review 2.  Genetic modifiers of sickle cell disease.

Authors:  Martin H Steinberg; Paola Sebastiani
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

3.  Enhanced Long-Term Brain Magnetic Resonance Imaging Evaluation of Children with Sickle Cell Disease after Hematopoietic Cell Transplantation.

Authors:  Nancy S Green; Monica Bhatia; Erica Y Griffith; Mahvish Qureshi; Courtney Briamonte; Mirko Savone; Stephen Sands; Margaret T Lee; Angela Lignelli; Adam M Brickman
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-09       Impact factor: 5.742

4.  Robust clinical and laboratory response to hydroxyurea using pharmacokinetically guided dosing for young children with sickle cell anemia.

Authors:  Patrick T McGann; Omar Niss; Min Dong; Anu Marahatta; Thad A Howard; Tomoyuki Mizuno; Adam Lane; Theodosia A Kalfa; Punam Malik; Charles T Quinn; Russell E Ware; Alexander A Vinks
Journal:  Am J Hematol       Date:  2019-06-12       Impact factor: 10.047

5.  Parent education and biologic factors influence on cognition in sickle cell anemia.

Authors:  Allison A King; John J Strouse; Mark J Rodeghier; Bruce E Compas; James F Casella; Robert C McKinstry; Michael J Noetzel; Charles T Quinn; Rebecca Ichord; Michael M Dowling; J Philip Miller; Michael R Debaun
Journal:  Am J Hematol       Date:  2014-02       Impact factor: 10.047

Review 6.  Interventions for preventing silent cerebral infarcts in people with sickle cell disease.

Authors:  Lise J Estcourt; Patricia M Fortin; Sally Hopewell; Marialena Trivella; Carolyn Doree; Miguel R Abboud
Journal:  Cochrane Database Syst Rev       Date:  2017-05-13

7.  Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.

Authors:  Michael R DeBaun; Mae Gordon; Robert C McKinstry; Michael J Noetzel; Desiree A White; Sharada A Sarnaik; Emily R Meier; Thomas H Howard; Suvankar Majumdar; Baba P D Inusa; Paul T Telfer; Melanie Kirby-Allen; Timothy L McCavit; Annie Kamdem; Gladstone Airewele; Gerald M Woods; Brian Berman; Julie A Panepinto; Beng R Fuh; Janet L Kwiatkowski; Allison A King; Jason M Fixler; Melissa M Rhodes; Alexis A Thompson; Mark E Heiny; Rupa C Redding-Lallinger; Fenella J Kirkham; Natalia Dixon; Corina E Gonzalez; Karen A Kalinyak; Charles T Quinn; John J Strouse; J Philip Miller; Harold Lehmann; Michael A Kraut; William S Ball; Deborah Hirtz; James F Casella
Journal:  N Engl J Med       Date:  2014-08-21       Impact factor: 91.245

Review 8.  Sickle cell disease: a malady beyond a hemoglobin defect in cerebrovascular disease.

Authors:  Junaid Ansari; Youmna E Moufarrej; Rafal Pawlinski; Felicity N E Gavins
Journal:  Expert Rev Hematol       Date:  2017-12-05       Impact factor: 2.929

9.  Headache and migraine in children with sickle cell disease are associated with lower hemoglobin and higher pain event rates but not silent cerebral infarction.

Authors:  Michael M Dowling; Michael J Noetzel; Mark J Rodeghier; Charles T Quinn; Deborah G Hirtz; Rebecca N Ichord; Janet L Kwiatkowski; E Steven Roach; Fenella J Kirkham; James F Casella; Michael R DeBaun
Journal:  J Pediatr       Date:  2014-02-13       Impact factor: 4.406

10.  Thrombospondin-1 and L-selectin are associated with silent cerebral infarct in children with sickle cell anaemia.

Authors:  Lisa M Faulcon; Zongming Fu; Pratima Dulloor; Emily Barron-Casella; William Savage; Jacky M Jennings; Jennifer E Van Eyk; Michael Debaun; James F Casella; Allen Everett
Journal:  Br J Haematol       Date:  2013-05-14       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.